Dynamic Learning in Depression
1 other identifier
interventional
120
1 country
1
Brief Summary
This study will assess learning bias (the tendency to learn more from negative relative to positive outcomes) at baseline in 3 groups of participants (currently depressed, previously depressed and never depressed). It will then try to modify this bias using a simple computerised training task completed at home daily for 2 weeks. Outcome measures include symptoms of depression, cognitive measures (i.e. accuracy and reaction time during completion of tasks), pupillometry measures and salivary cortisol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Nov 2016
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2016
CompletedFirst Posted
Study publicly available on registry
September 26, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2020
CompletedJune 16, 2020
April 1, 2019
3.6 years
September 22, 2016
June 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quick Inventory of Depressive Symptoms (self report, 16 item)
Standard questionnaire measure of depressive symptoms
change between baseline and week 6
Secondary Outcomes (5)
Quick Inventory of Depressive Symptoms (self report, 16 item)
change between baseline and week 2
Montgomery Asberg Depression Rating Scale
change from baseline to week 2 and 6
Learning parameters from information bias assessment task
baseline to weeks 2 and 6
Salivary cortisol concentration
baseline to weeks 2 and 6
Learning parameters derived from pupillometry data
baseline to weeks 2 and 6
Other Outcomes (5)
Speilberger State and Trait Anxiety Inventory
Baseline to weeks 2 and 6
Depressive Attributes Questionnaire
baseline to weeks 2 and 6
Rumination Response Scale
baseline to weeks 2 and 6
- +2 more other outcomes
Study Arms (2)
IBLT (information bias learning task)
EXPERIMENTALComputerised task in which most information is provided by positive outcomes. Completed for 10 mins per day every day for 2 weeks.
IBLT control
PLACEBO COMPARATORComputerised task in which information is provided by both positive and negative outcomes. Completed 10 mins per day every day for 2 weeks
Interventions
Information bias learning task-- a computer based task in which positive information is more useful when learning how best to complete it
A control version of the IBLT task-- a computer based task in which both positive and negative information is useful when learning how to complete it
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 to 60 years.
- Fluent in English.
- Not currently taking any psychoactive medications (except hormone contraceptives).
- Currently meets SCID (Structured Clinical Interview for Diagnosis:DSMV) criteria for MDD--Major Depressive Disorder-- (currently depressed group only).
- Meets SCID criteria for 2 or more previous episodes of MDD, has been in remission for at least 3 months (previously depressed group only).
- No previous or current axis I diagnosis (control group only).
You may not qualify if:
- Previous or current diagnosis of bipolar disorder or psychotic illness.
- Previous or current anxiety disorder (control group only, anxiety disorder is permitted in current and previously depressed group as long as primary diagnosis of MDD (current or previous) is present).
- Significant suicidal ideation.
- Use of drug of abuse within the last 3 months.
- Receiving treatment (either pharmacological or psychological) for psychiatric condition.
- Medical or surgical treatment which prevents dilation/constriction of pupil.
- Prior experience of the tasks used in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept of Psychiatry, University of Oxford
Oxford, Oxfordshire, OX3 7JX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Browning, MB.BS
University of Oxford
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2016
First Posted
September 26, 2016
Study Start
November 1, 2016
Primary Completion
June 3, 2020
Study Completion
June 3, 2020
Last Updated
June 16, 2020
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will share
Anonymised data will be shared with researchers who contact the PI after study completion.